CS logo
small CS logo
University of Pennsylvania Center for Weight and Eating Disorders

Philadelphia, Pennsylvania, United States
Weight loss service in Philadelphia, Pennsylvania
3535 Market St # 3108, Philadelphia, PA 19104

About University of Pennsylvania Center for Weight and Eating Disorders


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at University of Pennsylvania Center for Weight and Eating Disorders


During the past decade, University of Pennsylvania Center for Weight and Eating Disorders conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
1999-11-01
Completed
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Ixabepilone in Treating Patients With Metastatic Prostate Cancer
2004-09-01
2011-02-01
Completed
124
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
2004-10-26
Active, not recruiting
452
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
2005-03-21
2022-02-22
Active, not recruiting
1,157
CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
2005-05-01
2012-03-01
Completed
71

Rows per page:

1–100 of 304

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Pennsylvania Center for Weight and Eating Disorders" #1 sponsor was "University of Pennsylvania" with 13 trials, followed by "Epitomee medical" with 2 trials sponsored, "Aspire Bariatrics, Inc." with 1 trials sponsored, "Medical University of South Carolina" with 1 trials sponsored and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pennsylvania Center for Weight and Eating Disorders" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 8 trials as a collaborator, "University of Pennsylvania" with 4 trials as a collaborator, "Novo Nordisk A/S" with 2 trials as a collaborator, "Weight Watchers International" with 2 trials as a collaborator and "Baylor College of Medicine" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at University of Pennsylvania Center for Weight and Eating Disorders


According to Clinical.Site data, the most researched conditions in "University of Pennsylvania Center for Weight and Eating Disorders" are "Obesity" (16 trials), "Type 2 Diabetes" (3 trials), "Overweight and Obesity" (2 trials), "Adolescent Obesity" (1 trials) and "Dietary Intake" (1 trials). Many other conditions were trialed in "University of Pennsylvania Center for Weight and Eating Disorders" in a lesser frequency.

Clinical Trials Intervention Types at University of Pennsylvania Center for Weight and Eating Disorders


Most popular intervention types in "University of Pennsylvania Center for Weight and Eating Disorders" are "Behavioral" (15 trials), "Other" (7 trials), "Drug" (4 trials), "Device" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Behavioral Treatment" (2 trials), "Eating Condition" (2 trials), "Epitomee Capsule" (2 trials) and "Phentermine 15 MG" (2 trials). Other intervention names were less common.

Clinical Trials Genders at University of Pennsylvania Center for Weight and Eating Disorders


The vast majority of trials in "University of Pennsylvania Center for Weight and Eating Disorders" are 20 trials for "All" genders.

Clinical Trials Status at University of Pennsylvania Center for Weight and Eating Disorders


Currently, there are NaN active trials in "University of Pennsylvania Center for Weight and Eating Disorders". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in University of Pennsylvania Center for Weight and Eating Disorders, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Pennsylvania Center for Weight and Eating Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 14 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status